Comparison of drug‐eluting stents with bare metal stents in unselected patients with acute myocardial infarction

Abstract

The routine use of DES in acute myocardial infarction is associated with reduced rates of MACE at 12 months vs BMS, despite a higher rate of complex procedures in the DES treated patients. In addition to its anti-restenosis effect, the improved outcome of patients treated with DES may be linked to a more complete revascularization in association with prolonged clopidogrel therapy.

Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction

“…Conversely, our study does not show a benefit on TVR with DES [9,10,21,22]. Further, the DES TVR rate (10.4%) is double that of the randomised studies.…”

Repeat intervention after invasive treatment of coronary arteries☆

“…This may result in fewer recurrent symptoms in mid-term but also in long-term follow-up after surgery. In the future DES will continue to replace bare-metal stents (BMS) in primary percutaneous interventions [18,19], but surgery may still be considered more appropriate than stenting with DES for multi vessel CAD [20,21], especially in diabetics [22]. Finally, secondary prevention of the CAD may offer the greatest opportunity to improve long-term outcomes after mechanical interventions [17].…”

Coronary Stent and Prosthetic Heart Valve Information via Smartphone New Applications Improving Health-Care Quality of Patients Having Undergone Percutaneous Coronary Intervention and Artificial Valve Replacement

“…There are a huge number of patients who have been treated by percutaneous coronary intervention (PCI) with stenting (Kupferwasser, et al 2007). Two types of stents are used commonly for PCI; bare-metal stent and drug-eluting stent (Brodie, et al 2008).…”